Raptor Pharmaceuticals

US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis

US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis

Pharmabiz

Raptor's FDA Approval Is New Test For Orphan Drug Pricing

Raptor's FDA Approval Is New Test For Orphan Drug Pricing

TheStreet.com

2 Orphan Drugmakers With Upcoming Catalysts

2 Orphan Drugmakers With Upcoming Catalysts

Seeking Alpha

Procysbi (Raptor Pharmaceuticals): A Long Acting Cysteine For The Treatment Of Cystinosis

Procysbi (Raptor Pharmaceuticals): A Long Acting Cysteine For The Treatment Of Cystinosis

Seeking Alpha

Best And Worst FDA Drug Approval Stocks of 2013

Best And Worst FDA Drug Approval Stocks of 2013

TheStreet.com

Why Raptor Could Run Up To Its PDUFA

Why Raptor Could Run Up To Its PDUFA

Seeking Alpha

3 Big Stories Health-Care Investors Should Be Watching This Week

3 Big Stories Health-Care Investors Should Be Watching This Week

Motley Fool

Raptor Drug FDA Action Date Delayed

Raptor Drug FDA Action Date Delayed

Yahoo/Zacks

Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End

Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End

Seeking Alpha